Synjardy recalls
Synjardy products have been recalled 3 times, most recently on 2 Jun 2021. The recalling company is usually Cardinal Health. The most common reason is manufacturing (cgmp) deviations.
Total recalls3since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why synjardy is recalled
Companies
Product types
By year
All synjardy recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Synjardy XR (empagliflozin and metformin hydrochloride recalledSynjardy | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Synjardy XR (empagliflozin and metformin) hydrochloride recalledSynjardy | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Synjardy (empagliflozin and metformin hydrochloride) Tablets recalledSynjardy | Boehringer Ingelheim Pharmaceuticals | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.